+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lung Cancer Surgery Market by Approach, Product Type, Cancer Type, End User - Global Forecast to 2030- Product Image
Lung Cancer Surgery Market by Approach, Product Type, Cancer Type, End User - Global Forecast to 2030- Product Image
Sale

Lung Cancer Surgery Market by Approach, Product Type, Cancer Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674625
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Lung Cancer Surgery Market grew from USD 6.01 billion in 2024 to USD 6.38 billion in 2025. It is expected to continue growing at a CAGR of 5.95%, reaching USD 8.50 billion by 2030.

Navigating the Evolving Lung Cancer Surgery Terrain

The landscape of lung cancer surgery is undergoing rapid transformation as technological breakthroughs and shifting patient needs converge to redefine treatment paradigms. In recent years, the drive toward less invasive options and enhanced operative precision has accelerated the adoption of innovative surgical approaches. Concurrently, global health systems are grappling with policy reforms and cost containment pressures that influence equipment procurement and procedural choices. Decision-makers must navigate this dynamic environment armed with a clear understanding of emerging trends, regulatory developments, and the competitive forces at play. This executive summary frames the critical forces shaping the lung cancer surgery market and outlines the analytical framework that underpins our comprehensive study.

Emerging Forces Reshaping Surgical Practice

A series of paradigm shifts is redefining the way surgeons approach lung cancer procedures. Advances in robotics have elevated the precision of minimally invasive thoracic operations, enabling complex resections through smaller incisions while reducing patient recovery times. At the same time, refinements in video-assisted techniques are broadening the scope of early-stage resection by enhancing visual clarity and surgical ergonomics. These technological strides coincide with growing emphasis on multidisciplinary care pathways that integrate preoperative imaging, genomic profiling, and postoperative rehabilitation to optimize outcomes. As market participants strive to differentiate their offerings, the pace of innovation and the agility to integrate complementary technologies will determine competitive positioning.

Unpacking the 2025 US Tariff Shockwave

The implementation of new tariffs on medical imports in the United States as of early 2025 has introduced material complexity to procurement strategies across healthcare institutions. Equipment manufacturers and suppliers are re-evaluating their supply chains, seeking alternative sourcing strategies, local production partnerships, and pricing models that absorb or mitigate added duties. For hospitals committed to expanding minimally invasive surgical programs, these cost pressures underscore the importance of negotiating value-based agreements and exploring device reprocessing options. Furthermore, the ripple effects on accessory purchases and maintenance service contracts have prompted health system leaders to forecast budget impacts with greater rigor, ensuring that care quality remains uncompromised despite heightened financial constraints.

Deep Dive into Surgical Market Segmentation

A nuanced segmentation framework reveals divergent growth vectors and underserved opportunities within the lung cancer surgery domain. When examining procedural approach, the shift from open surgery toward minimally invasive techniques stands out, driven by patient preference for accelerated recovery and reduced postoperative pain. Within the minimally invasive segment, robotic-assisted thoracic surgery has surged ahead, anchored by leading robotic platforms that deliver enhanced dexterity and three-dimensional visualization. Video-assisted thoracoscopic surgery retains a strong foothold, supported by both multiportal access that facilitates triangulation of instruments and the emerging uniportal technique that streamlines incision management. In dissecting the product portfolio, access devices and trocars remain foundational, yet the integration of advanced endoscopes and high-definition visualization systems is transforming intraoperative decision-making. Energy devices span a spectrum from advanced bipolar instruments to ultrasonic shears, offering versatility in tissue sealing and dissection, while the evolution of stapling solutions-ranging from manual reload systems to powered staplers-has elevated surgical efficiency and staple line consistency. Delving into cancer subtype applications, non small cell lung carcinoma dominates procedural volume, with adenocarcinoma representing the majority share, followed by squamous cell and large cell variants each presenting unique anatomical and margin considerations. Meanwhile, surgical interventions for small cell lung cancer are typically reserved for limited-stage presentations, emphasizing the critical role of accurate staging and multidisciplinary tumor boards. Finally, the end user landscape bifurcates between ambulatory surgical centers capitalizing on streamlined day-case procedures and major hospital systems that integrate comprehensive oncology services, interventional radiology, and dedicated post-anesthesia care units.

Geographic Hotspots and Regional Dynamics

Regional analysis underscores significant heterogeneity in adoption rates, regulatory frameworks, and reimbursement landscapes. In the Americas, robust healthcare infrastructure combined with favorable capital investment policies supports rapid uptake of robotic platforms and advanced visualization systems, yet cost containment initiatives at the payer level are prompting providers to demonstrate value through quality metrics and patient-reported outcomes. The Europe, Middle East & Africa region presents a mosaic of opportunities as national health authorities in Western Europe maintain structured evaluation pathways for novel devices, while emerging markets in the Middle East and Africa pursue public-private partnerships to bolster surgical capabilities and expand access. Across Asia-Pacific, the convergence of growing patient populations, rising healthcare expenditure, and proactive medical device approval processes is fueling demand for minimally invasive solutions, particularly in markets where large thoracic surgery centers serve as regional centers of excellence.

Innovators Driving Surgical Advances

A handful of global medtech companies and agile innovators are shaping the competitive dynamics in lung cancer surgery. Leading robotic platform providers have fortified their market positions through iterative upgrades, expanding instrument libraries, and strategic partnerships with surgical training centers. Meanwhile, specialist manufacturers of endoscopes and visualization systems are leveraging modular designs and software-driven enhancements to deliver real-time analytics and image fusion capabilities. In the energy device category, established players have broadened their offerings to include multifunctional surgical instruments that integrate sealing, cutting, and vessel monitoring, targeting efficiency gains and reduced device inventory. Stapling device manufacturers are racing to commercialize powered systems with automated firing algorithms that promise consistent staple formation across varied tissue thicknesses. A parallel trend involves emerging biopharma-device collaborations that explore adjunctive use of localized drug delivery in resection margins, signaling a potential next frontier in combination therapy.

Strategic Imperatives for Market Leadership

To capitalize on emerging opportunities and navigate evolving headwinds, industry leaders should adopt a threefold strategic approach. First, invest in end-to-end solutions that integrate hardware, software, and service offerings to create stickier customer relationships and demonstrate measurable clinical value. Second, pursue targeted partnerships with academic medical centers to co-develop next-generation instruments and validate outcomes through real-world evidence studies. Third, refine commercial models to align with shifting reimbursement paradigms-exploring subscription-based access, outcome-based pricing, and bundled procedure agreements that tie device utilization to patient recovery milestones. By balancing deep clinical engagement with agile business practices, organizations can drive adoption, optimize cost structures, and maintain a competitive edge in this high-stakes market.

Rigorous Framework Underpinning Analysis

This analysis employs a mixed-method research framework combining extensive secondary literature review with qualitative primary interviews. Peer-reviewed journals, regulatory filings, and health economics publications formed the basis for triangulating technology trends and clinical outcomes. Supplier annual reports, investor presentations, and patent databases were scrutinized to map competitive landscapes and innovation pipelines. In parallel, structured interviews with thoracic surgeons, hospital procurement leaders, and industry experts provided grounded perspectives on adoption barriers, procedural preferences, and value perceptions. Data synthesis followed a thematic coding protocol to ensure consistency, while internal validation workshops were conducted to challenge assumptions and refine strategic insights. The resulting report captures both quantitative benchmarks and qualitative narratives, delivering a holistic view of the lung cancer surgery ecosystem.

Empowering Decision-Makers Through Insight

The surgical oncology market for lung cancer stands at a crossroads where technological prowess, economic constraints, and patient-centric care models intersect. Stakeholders poised to leverage minimally invasive advances, articulate compelling value propositions, and adapt to regional reimbursement nuances will lead the next wave of growth. Simultaneously, the imperative to validate outcomes through robust clinical evidence and real-world data will intensify, shaping procurement decisions and influencing clinician adoption. By embracing an integrated perspective on segmentation, geography, and competitive positioning, decision-makers can chart a path that balances innovation with sustainability, ensuring that patients worldwide benefit from safer, more effective surgical interventions.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Approach
    • Minimally Invasive
      • Robotic Assisted Thoracic Surgery (Rats)
        • Da Vinci Systems
      • Video Assisted Thoracoscopic Surgery (Vats)
        • Multiportal
        • Uniportal
    • Open Surgery
  • Product Type
    • Access Devices And Trocars
    • Endoscopes And Visualization Systems
    • Energy Devices
      • Advanced Bipolar Devices
      • Electrosurgical Devices
      • Ultrasonic Energy Devices
    • Stapling Devices
      • Manual Staplers
      • Powered Staplers
  • Cancer Type
    • Non Small Cell Lung Cancer
      • Adenocarcinoma
      • Large Cell Carcinoma
      • Squamous Cell Carcinoma
    • Small Cell Lung Cancer
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Intuitive Surgical, Inc.
  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Olympus Corporation
  • KARL STORZ SE & Co. KG
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Smith & Nephew plc
  • Zimmer Biomet Holdings, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Lung Cancer Surgery Market, by Approach
8.1. Introduction
8.2. Minimally Invasive
8.2.1. Robotic Assisted Thoracic Surgery (Rats)
8.2.1.1. Da Vinci Systems
8.2.2. Video Assisted Thoracoscopic Surgery (Vats)
8.2.2.1. Multiportal
8.2.2.2. Uniportal
8.3. Open Surgery
9. Lung Cancer Surgery Market, by Product Type
9.1. Introduction
9.2. Access Devices and Trocars
9.3. Endoscopes and Visualization Systems
9.4. Energy Devices
9.4.1. Advanced Bipolar Devices
9.4.2. Electrosurgical Devices
9.4.3. Ultrasonic Energy Devices
9.5. Stapling Devices
9.5.1. Manual Staplers
9.5.2. Powered Staplers
10. Lung Cancer Surgery Market, by Cancer Type
10.1. Introduction
10.2. Non Small Cell Lung Cancer
10.2.1. Adenocarcinoma
10.2.2. Large Cell Carcinoma
10.2.3. Squamous Cell Carcinoma
10.3. Small Cell Lung Cancer
11. Lung Cancer Surgery Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
12. Americas Lung Cancer Surgery Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Lung Cancer Surgery Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Lung Cancer Surgery Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Intuitive Surgical, Inc.
15.3.2. Medtronic plc
15.3.3. Johnson & Johnson
15.3.4. Stryker Corporation
15.3.5. Olympus Corporation
15.3.6. KARL STORZ SE & Co. KG
15.3.7. Becton Dickinson and Company
15.3.8. Boston Scientific Corporation
15.3.9. Smith & Nephew plc
15.3.10. Zimmer Biomet Holdings, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. LUNG CANCER SURGERY MARKET MULTI-CURRENCY
FIGURE 2. LUNG CANCER SURGERY MARKET MULTI-LANGUAGE
FIGURE 3. LUNG CANCER SURGERY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. LUNG CANCER SURGERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. LUNG CANCER SURGERY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. LUNG CANCER SURGERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY DA VINCI SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 11. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MULTIPORTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY UNIPORTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 15. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ACCESS DEVICES AND TROCARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ADVANCED BIPOLAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ULTRASONIC ENERGY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MANUAL STAPLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY POWERED STAPLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ADENOCARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY LARGE CELL CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SMALL CELL LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 42. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 43. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. CANADA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 62. CANADA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 63. CANADA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 64. CANADA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 65. CANADA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 67. CANADA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 68. CANADA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 69. CANADA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 70. CANADA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 72. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 74. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 75. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 77. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 80. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 84. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 85. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 123. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 125. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 126. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 128. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 129. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 130. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 131. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 133. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 134. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 135. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 136. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 138. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 139. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 140. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 141. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 145. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 146. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. ITALY LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 153. ITALY LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 154. ITALY LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 155. ITALY LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 156. ITALY LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. ITALY LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 158. ITALY LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 159. ITALY LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 160. ITALY LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 161. ITALY LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 163. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 165. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 166. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 168. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 169. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 171. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 203. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 204. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 205. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 206. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 208. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 209. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 210. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 211. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. QATAR LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 223. QATAR LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 224. QATAR LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 225. QATAR LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 226. QATAR LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. QATAR LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 228. QATAR LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 229. QATAR LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 230. QATAR LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 231. QATAR LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 233. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 234. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 235. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 236. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 238. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 239. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 240. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 241. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 243. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 245. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 246. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 253. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 255. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 256. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 263. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 264. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 265. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 266. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 268. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 269. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 270. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 271. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 273. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 274. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 275. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 276. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 278. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 279. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 280. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 281. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 285. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 286. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 293. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 294. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 295. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 296. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 298. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 299. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 300. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 301. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. POLAND LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 303. POLAND LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 304. POLAND LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 305. POLAND LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 306. POLAND LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. POLAND LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 308. POLAND LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 309. POLAND LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 310. POLAND LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 311. POLAND LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 313. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 314. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 315. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 316. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY END USER

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Lung Cancer Surgery market report include:
  • Intuitive Surgical, Inc.
  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Olympus Corporation
  • KARL STORZ SE & Co. KG
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Smith & Nephew plc
  • Zimmer Biomet Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.38 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.5 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Lung Cancer Surgery Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Lung Cancer Surgery Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Lung Cancer Surgery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Lung Cancer Surgery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Lung Cancer Surgery - Global Strategic Business Report - Product Image

Lung Cancer Surgery - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From
Thoracic Surgery Market Report and Forecast 2024-2032 - Product Image

Thoracic Surgery Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Minimally Invasive Thoracic Surgery - Global Strategic Business Report - Product Image

Minimally Invasive Thoracic Surgery - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From

About the Lung Cancer Surgery Market

Lung cancer surgery is a medical procedure used to treat lung cancer. It is often used in combination with other treatments such as chemotherapy and radiation therapy. The goal of surgery is to remove the cancerous tissue and any surrounding tissue that may be affected. Surgery is usually the first line of treatment for early-stage lung cancer, and may be used in more advanced stages as well. The lung cancer surgery market is a subset of the larger lung cancer drugs market. It is composed of medical devices, surgical instruments, and other products used in the surgical treatment of lung cancer. Companies in this market include medical device manufacturers, surgical instrument suppliers, and other companies that provide products and services related to lung cancer surgery. Some companies in the lung cancer surgery market include Medtronic, Stryker, Johnson & Johnson, Becton Dickinson, and Smith & Nephew. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.